logo

For the Inventor, By the Inventor

Ledyard, CT, United States of America

Paul R McGuirk

USPTO Granted Patents = 13

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 100(Granted Patents)


Location History:

  • Gales Ferry, CT (US) (1986 - 1993)
  • Groton, CT (US) (1993)
  • Ledyard, CT (US) (1991 - 2001)

Company Filing History:

goldMedal13 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1986-2001

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6300316 - C-4 substituted macrolide antibiotics (2001-10-09),
2. 5385913 - 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian (1995-01-31),
3. 5233091 - 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and (1993-08-03),
4. 5214051 - Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic (1993-05-25),
5. 5104868 - Tricyclic derivatives of (1992-04-14),
6. 5103040 - 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and (1992-04-07),
7. 5091383 - Substituted bridged diazabicycloalkyl quinolone carboxylic acids (1992-02-25),
8. 5039682 - 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and (1991-08-13),
9. 5037834 - Heterocycylic-substituted quinoline-carboxylic acids (1991-08-06),
10. 4797490 - Process for the preparation of 3-(2'-fluorophenyl)pyridine (1989-01-10),
11. 4775668 - Substituted bridged-diazabicycloalkyl quinolone carboxylic acids and (1988-10-04),
12. 4636506 - 7-heterocyclic-1,4-dihydroquinolones (1987-01-13),
13. 4623650 - Antibiotic derivatives of (1986-11-18),

Title: The Innovative Journey of Paul R. McGuirk

Introduction

Paul R. McGuirk, an esteemed inventor based in Ledyard, CT, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 13 patents, he has established himself as a key player in the development of innovative medical compounds. His work primarily focuses on advancements in antibiotic therapies, which hold the potential to improve healthcare outcomes globally.

Latest Patents

Among his notable inventions is a groundbreaking patent for C-4 substituted macrolide antibiotics. This invention relates to compounds of the formula 1,4-dihydro-4-oxo-3-quinoline derivatives, known for their selectively toxic effects on mammalian cells. This advancement may pave the way for enhanced treatment options, combating various bacterial infections more effectively.

Career Highlights

Paul R. McGuirk's career has been closely associated with Pfizer Corporation, where he dedicates his expertise to cutting-edge research and development. His work has greatly contributed to the pharmaceutical advancements that the company is renowned for. McGuirk’s commitment to innovation and excellence has not gone unnoticed, as he continues to make strides in the field of antibiotic research.

Collaborations

Throughout his career, McGuirk has had the opportunity to work with several talented individuals, including coworkers Paul J. Gilligan and Michael John Witty. These collaborations have enriched his research efforts and fostered a fruitful environment for developing groundbreaking medical solutions.

Conclusion

In conclusion, Paul R. McGuirk exemplifies the spirit of innovation and dedication in the pharmaceutical industry. His contributions to antibiotic research underscore the vital role of inventors in driving advancements that can lead to healthier lives. With his continued efforts, McGuirk is poised to make a lasting impact in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…